Holdings
Foresite Capital Management VI LLC
As of Sep 30, 2026, Foresite Capital Management VI LLC reported 19 positions worth US$495M. Largest: CG Oncology, Inc., Latigo Biotherapeutics, Inc. and Seaport Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| CG Oncology, Inc. | 2.11M | US$150M | −260K | Sep 30, 2026 |
| Latigo Biotherapeutics, Inc. | 2.2M | US$36.8M | new | Sep 30, 2026 |
| Seaport Therapeutics, Inc. | 1.78M | US$35.9M | no change | Sep 30, 2026 |
| Denali Therapeutics Inc. | 1.62M | US$33.4M | +221K | Sep 30, 2026 |
| Parabilis Medicines, Inc. | 999K | US$32.3M | no change | Sep 30, 2026 |
| Alumis Inc. | 4.25M | US$31.4M | no change | Sep 30, 2026 |
| Agios Pharmaceuticals, Inc. | 827K | US$27.5M | +42,128 | Sep 30, 2026 |
| Verastem, Inc. | 3.15M | US$25.3M | no change | Sep 30, 2026 |
| Corvus Pharmaceuticals, Inc. | 1.83M | US$21.1M | no change | Sep 30, 2026 |
| Kymera Therapeutics, Inc. | 146K | US$16.4M | no change | Sep 30, 2026 |